EI
ANGO icon

EAM Investors’s AngioDynamics ANGO Stock Holding History

EAM Investors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-95,278
Closed -$1.22M – 281
2025
Q4 		$1.22M Buy
+95,278
New +$1.18M 0.14% 188
2025
Q3 		– Sell
-44,969
Closed -$446K – 260
2025
Q2 		$446K Sell
44,969
-290,550
-87% -$2.84M 0.07% 215
2025
Q1 		$3.15M Buy
+335,519
New +$3.53M 0.54% 89
2021
Q3 		– Sell
-151,566
Closed -$4.11M – 284
2021
Q2 		$4.11M Buy
+151,566
New +$3.7M 0.64% 16
2018
Q3 		– Sell
-195,553
Closed -$4.35M – 300
2018
Q2 		$4.35M Buy
+195,553
New +$4M 0.69% 17
2015
Q1 		– Sell
-63,624
Closed -$1.21M – 325
2014
Q4 		$1.21M Buy
+63,624
New +$1.08M 0.17% 254
2014
Q1 		– Sell
-76,968
Closed -$1.32M – 310
2013
Q4 		$1.32M Buy
+76,968
New +$1.18M 0.24% 213

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $118M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $295M AUM 19.08% 1-Year Est. Return

EAM Investors's ANGO Position: Q1 2026 in Review

EAM Investors sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 95,278 shares — an estimated $1.22M sold.

EAM Investors first reported a position in ANGO in Q4 2013 and held it in 7 quarters. The position peaked at $4.35M in Q2 2018. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • EAM Investors reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
  • EAM Investors sold 95,278 AngioDynamics shares in Q1 2026, an estimated $1.22M.
  • EAM Investors first reported a position in AngioDynamics in Q4 2013 and held it in 7 quarters.
  • EAM Investors's AngioDynamics position peaked at $4.35M in Q2 2018.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.